Vizgen Stock
HealthTechLooking to sell Vizgen stock or options?
Vizgen has developed a biomolecule profiling technology aimed at providing new insights into biological systems and diseases. The company's innovation centers on harnessing spatially resolved, single-cell gene expression profiling within intact tissue slices by utilizing spatial gene profiling measurements. This allows medical researchers to effectively explore biology at a systems level.
Investors Include:
Blue Water Life Science Fund, Northpond Ventures, ARCH Venture Partners, Tao Capital Partners, David Walt, Pura Vida Investments, Novalis LifeSciences, Sofina.